Next Article in Journal
Comprehensive Genomic Profiling in the Management of Ovarian Cancer—National Results from Croatia
Previous Article in Journal
Self-Assessment of Knowledge on the Treatment of Children and Adolescents with Special Care Needs: Results of a Survey amongst German Dentists with Key Expertise in Paediatric Dentistry
 
 
Article
Peer-Review Record

Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease

J. Pers. Med. 2022, 12(7), 1174; https://doi.org/10.3390/jpm12071174
by Maurizio Benucci 1,*, Arianna Damiani 1, Francesca Bandinelli 1, Edda Russo 2, Francesca Li Gobbi 1, Valentina Grossi 3, Amedeo Amedei 2, Maria Infantino 3 and Mariangela Manfredi 3
Reviewer 1:
Reviewer 2:
J. Pers. Med. 2022, 12(7), 1174; https://doi.org/10.3390/jpm12071174
Submission received: 15 June 2022 / Revised: 13 July 2022 / Accepted: 14 July 2022 / Published: 19 July 2022 / Corrected: 18 January 2023

Round 1

Reviewer 1 Report

Authors presented their research on the effect of switching of biosimilar from its reference drug and the correlation of drug levels and TNF activity in evaluating responders and non responder patient population.

The study is well written with clear intro, methodology, results and discussion.

Needs minor English correction.

 

Author Response

We thank the reviewer for the positive feedback. In accordance with the suggestion of the reviewer, we uploaded a new version of the article with English corrections.

Author Response File: Author Response.docx

Reviewer 2 Report

I congratulate the authors for considering that the purpose of this study is to be the first to investigate how NMS between Etanercept(ETN)/source and SB4/biosimilar in a multiple RD cohort affects the efficacy of treatment. 

Author Response

We thank the reviewer for appreciating our study, we are really glad to have had its positive feedback .   
Back to TopTop